![]() Ritonavir-d6 structure
|
Common Name | Ritonavir-d6 | ||
---|---|---|---|---|
CAS Number | 1217720-20-1 | Molecular Weight | 726.98 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C37H42D6N6O5S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Ritonavir-d6Ritonavir-d6 (ABT 538-d6) is the deuterium labeled Ritonavir. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM[1][2]. |
Name | RITONAVIR-D6 |
---|
Description | Ritonavir-d6 (ABT 538-d6) is the deuterium labeled Ritonavir. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C37H42D6N6O5S2 |
---|---|
Molecular Weight | 726.98 |
Storage condition | -20°C Freezer, Under Inert Atmosphere |
Hazard Codes | Xi |
---|